Analysis of the promoter of the MUC1 gene overexpressed in breast cancer

Joseph Z. Zaretsky; Ronit Sarid; Yael Aylon; Leonid A. Mittelman; Daniel H. Wreschner; Iafa Keydar

doi:10.1016/s0014-5793(99)01452-0

Analysis of the promoter of the MUC1 gene overexpressed in breast cancer

Joseph Z. Zaretsky, Ronit Sarid, Yael Aylon, Leonid A. Mittelman, Daniel H. Wreschner, Iafa Keydar

Tel Aviv University

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

The MUC1 gene encodes a mucin glycoprotein and is overexpressed in breast cancer. Knowledge of the mechanisms leading to MUC1 overexpression may help in the development of molecular approaches for breast cancer therapy. In order to study the regulation of the MUC1 gene transcription, we analyzed functional activities of various deletion mutants of the MUC1 promoter. We established that transcriptional cis-elements present in the SacI/XmnI fragment of the promoter are competent and sufficient for expression of, at least, tandem repeats containing isoform(s) of the MUC1 protein. CAT transfection analysis showed that both the 3' and 5' regions of the SacI/XmnI fragment possess transcription activities. Promoter activities associated with the SacI/XmnI fragment were confirmed by a RNase protection assay, which demonstrated multiple transcription start sites (TSSs) in the MUC1 gene transcribed in epithelial T47D cells. We show that treatment of the T47D cells with TGFβ1 leads to activation of additional TSSs in the MUC1 gene. The roles of the structural and functional properties of the MUC1 promoter in MUC1 gene transcription are discussed. Copyright (C) 1999 Federation of European Biochemical Societies.

Original language	English
Pages (from-to)	189-195
Number of pages	7
Journal	FEBS Letters
Volume	461
Issue number	3
DOIs	https://doi.org/10.1016/s0014-5793(99)01452-0
State	Published - 19 Nov 1999
Externally published	Yes

Bibliographical note

Funding Information:
We thank Dr M. Hareuveni for providing us with the pHMG/CL642/MUC1 plasmid, Dr I. Tsarfaty for pUN121 plasmid containing the MUC1 gene sequence, Prof. A. Yaniv and Prof. A. Gazit in whose laboratory the CAT assays were performed and Dr M. Gorivodsy for help in computer analysis. This research was supported by the Israel Cancer Association, the Simco Chair for Breast Cancer Research, the Federico Fund for Tel Aviv University and the Barbara Friedman Fund (I.K.) and Susan Komen Breast Cancer Foundation (D.H.W.).

Funding

We thank Dr M. Hareuveni for providing us with the pHMG/CL642/MUC1 plasmid, Dr I. Tsarfaty for pUN121 plasmid containing the MUC1 gene sequence, Prof. A. Yaniv and Prof. A. Gazit in whose laboratory the CAT assays were performed and Dr M. Gorivodsy for help in computer analysis. This research was supported by the Israel Cancer Association, the Simco Chair for Breast Cancer Research, the Federico Fund for Tel Aviv University and the Barbara Friedman Fund (I.K.) and Susan Komen Breast Cancer Foundation (D.H.W.).

Funders	Funder number
Barbara Friedman Fund
Susan G. Komen
Israel Cancer Association
Tel Aviv University

Keywords

CAT assay
MUC1 gene
Promoter
Transcription start site

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0014-5793(99)01452-0

Cite this

@article{303bfd923a924f10abff3d7220633b86,

title = "Analysis of the promoter of the MUC1 gene overexpressed in breast cancer",

abstract = "The MUC1 gene encodes a mucin glycoprotein and is overexpressed in breast cancer. Knowledge of the mechanisms leading to MUC1 overexpression may help in the development of molecular approaches for breast cancer therapy. In order to study the regulation of the MUC1 gene transcription, we analyzed functional activities of various deletion mutants of the MUC1 promoter. We established that transcriptional cis-elements present in the SacI/XmnI fragment of the promoter are competent and sufficient for expression of, at least, tandem repeats containing isoform(s) of the MUC1 protein. CAT transfection analysis showed that both the 3' and 5' regions of the SacI/XmnI fragment possess transcription activities. Promoter activities associated with the SacI/XmnI fragment were confirmed by a RNase protection assay, which demonstrated multiple transcription start sites (TSSs) in the MUC1 gene transcribed in epithelial T47D cells. We show that treatment of the T47D cells with TGFβ1 leads to activation of additional TSSs in the MUC1 gene. The roles of the structural and functional properties of the MUC1 promoter in MUC1 gene transcription are discussed. Copyright (C) 1999 Federation of European Biochemical Societies.",

keywords = "CAT assay, MUC1 gene, Promoter, Transcription start site",

author = "Zaretsky, {Joseph Z.} and Ronit Sarid and Yael Aylon and Mittelman, {Leonid A.} and Wreschner, {Daniel H.} and Iafa Keydar",

note = "Funding Information: We thank Dr M. Hareuveni for providing us with the pHMG/CL642/MUC1 plasmid, Dr I. Tsarfaty for pUN121 plasmid containing the MUC1 gene sequence, Prof. A. Yaniv and Prof. A. Gazit in whose laboratory the CAT assays were performed and Dr M. Gorivodsy for help in computer analysis. This research was supported by the Israel Cancer Association, the Simco Chair for Breast Cancer Research, the Federico Fund for Tel Aviv University and the Barbara Friedman Fund (I.K.) and Susan Komen Breast Cancer Foundation (D.H.W.).",

year = "1999",

month = nov,

day = "19",

doi = "10.1016/s0014-5793(99)01452-0",

language = "אנגלית",

volume = "461",

pages = "189--195",

journal = "FEBS Letters",

issn = "0014-5793",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Analysis of the promoter of the MUC1 gene overexpressed in breast cancer

AU - Zaretsky, Joseph Z.

AU - Sarid, Ronit

AU - Aylon, Yael

AU - Mittelman, Leonid A.

AU - Wreschner, Daniel H.

AU - Keydar, Iafa

N1 - Funding Information: We thank Dr M. Hareuveni for providing us with the pHMG/CL642/MUC1 plasmid, Dr I. Tsarfaty for pUN121 plasmid containing the MUC1 gene sequence, Prof. A. Yaniv and Prof. A. Gazit in whose laboratory the CAT assays were performed and Dr M. Gorivodsy for help in computer analysis. This research was supported by the Israel Cancer Association, the Simco Chair for Breast Cancer Research, the Federico Fund for Tel Aviv University and the Barbara Friedman Fund (I.K.) and Susan Komen Breast Cancer Foundation (D.H.W.).

PY - 1999/11/19

Y1 - 1999/11/19

N2 - The MUC1 gene encodes a mucin glycoprotein and is overexpressed in breast cancer. Knowledge of the mechanisms leading to MUC1 overexpression may help in the development of molecular approaches for breast cancer therapy. In order to study the regulation of the MUC1 gene transcription, we analyzed functional activities of various deletion mutants of the MUC1 promoter. We established that transcriptional cis-elements present in the SacI/XmnI fragment of the promoter are competent and sufficient for expression of, at least, tandem repeats containing isoform(s) of the MUC1 protein. CAT transfection analysis showed that both the 3' and 5' regions of the SacI/XmnI fragment possess transcription activities. Promoter activities associated with the SacI/XmnI fragment were confirmed by a RNase protection assay, which demonstrated multiple transcription start sites (TSSs) in the MUC1 gene transcribed in epithelial T47D cells. We show that treatment of the T47D cells with TGFβ1 leads to activation of additional TSSs in the MUC1 gene. The roles of the structural and functional properties of the MUC1 promoter in MUC1 gene transcription are discussed. Copyright (C) 1999 Federation of European Biochemical Societies.

AB - The MUC1 gene encodes a mucin glycoprotein and is overexpressed in breast cancer. Knowledge of the mechanisms leading to MUC1 overexpression may help in the development of molecular approaches for breast cancer therapy. In order to study the regulation of the MUC1 gene transcription, we analyzed functional activities of various deletion mutants of the MUC1 promoter. We established that transcriptional cis-elements present in the SacI/XmnI fragment of the promoter are competent and sufficient for expression of, at least, tandem repeats containing isoform(s) of the MUC1 protein. CAT transfection analysis showed that both the 3' and 5' regions of the SacI/XmnI fragment possess transcription activities. Promoter activities associated with the SacI/XmnI fragment were confirmed by a RNase protection assay, which demonstrated multiple transcription start sites (TSSs) in the MUC1 gene transcribed in epithelial T47D cells. We show that treatment of the T47D cells with TGFβ1 leads to activation of additional TSSs in the MUC1 gene. The roles of the structural and functional properties of the MUC1 promoter in MUC1 gene transcription are discussed. Copyright (C) 1999 Federation of European Biochemical Societies.

KW - CAT assay

KW - MUC1 gene

KW - Promoter

KW - Transcription start site

UR - http://www.scopus.com/inward/record.url?scp=0032744544&partnerID=8YFLogxK

U2 - 10.1016/s0014-5793(99)01452-0

DO - 10.1016/s0014-5793(99)01452-0

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 10567695

AN - SCOPUS:0032744544

SN - 0014-5793

VL - 461

SP - 189

EP - 195

JO - FEBS Letters

JF - FEBS Letters

IS - 3

ER -

Analysis of the promoter of the MUC1 gene overexpressed in breast cancer

Abstract

Bibliographical note

Funding

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this